Finer Market Points: ASX Top 10 Momentum Stocks: 26 Feb 2024 NASDAQ:PAA ASX:BRN MIL:BRE ASX:RIM ASX:DRO NYSE:FND GETTEX:STP NASDAQ:BVS ASX:RDM
Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appearing
−0.0125EUR
−3.79 MEUR
1.72 MEUR
250.75 M
About PHARMAUST LIMITED
Sector
CEO
John Clark
Headquarters
Claremont
Website
Founded
2000
ISIN
AU000000PAA1
FIGI
BBG000KM6DN8
PharmAust Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research, and Pharmaceutical-Epichem segments. The Corporate and Research segment includes corporate overhead expenses. The Pharmaceutical-Epichem segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company was founded on December 2003 and is headquartered in Claremont, Australia.
Finer Market Points: ASX Top 10 Momentum Stocks: 15 Feb 2024NYSE:ARR MIL:BRE ASX:RIM ASX:BRN ASX:ACW ASX:RDM GETTEX:CXU EURONEXT:CTT NASDAQ:PAA
Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appearing
PAA - Trade PlanPAA is trading currently n a descending wedge and is struggling to close above long term trendline. If it manages to close in the given spot (Green Circle Buy Zone), then it may confirm a change in trend and may get bullish, as this is a very Bullish structure. We need to see good volume and a thrus
$PAA - doggy spec biotech basing up. after the pump through 19 recently this thing has come back and tested support. Id suggest clearly not being bought up by funds. However, looking much better for a test of resistance on the hourly at 22.5c.
From the recent presentation, the next move was to test their drug against human lung tiss
$PAA wanted to see the break of May 12 high and close above.This is a biostock so, very high risk play. Been looking/waiting for the move above the May 12 high of 17.5c. Lets see how they close it this week. Their drug appears to be effective in suppressing the covid virus in cell culture. Human safety already achieved, so awaiting phase 1 trials.
$PAA:ASX - PHARMAUST - Up 170% over the last 3 monthsPharmAust is a clinical-stage company developing targeted cancer therapeutics for both humans and animals through re-purposing marketed drugs lowering the risks and costs of development. They look to have broken through a previous resistance area and could be worth a watch.
Current demand shows 76
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PHARMAUST LTD. stocks are traded under the ticker ECQ.
Yes, you can track PHARMAUST LTD. financials in yearly and quarterly reports right on TradingView.
ECQ net income for the last quarter is −240.08 K EUR, while the quarter before that showed −3.78 M EUR of net income which accounts for 93.65% change. Track more PHARMAUST LTD. financial stats to get the full picture.
No, ECQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ECQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMAUST LTD. stock right from TradingView charts — choose your broker and connect to your account.